0001104659-21-079413.txt : 20210610
0001104659-21-079413.hdr.sgml : 20210610
20210610160626
ACCESSION NUMBER: 0001104659-21-079413
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210608
FILED AS OF DATE: 20210610
DATE AS OF CHANGE: 20210610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Harshbarger Benjamin
CENTRAL INDEX KEY: 0001653133
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 211008114
MAIL ADDRESS:
STREET 1: ONE MAIN STREET, SUITE 800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 HIGH STREET
STREET 2: 28TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: 100 HIGH STREET
STREET 2: 28TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
tm2119390-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-06-08
0
0001454789
CATABASIS PHARMACEUTICALS INC
CATB
0001653133
Harshbarger Benjamin
C/O CATABASIS PHARMACEUTICALS, INC.,
100 HIGH STREET, FLOOR 28
BOSTON,
MA
02110
0
1
0
0
Chief Legal Officer
Stock Option (right to buy)
2.16
2021-06-08
4
A
0
200000
0
A
2031-06-07
Common Stock
200000
200000
D
The option is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of June 8, 2021 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.
/s/ Benjamin Harshbarger
2021-06-10